Literature DB >> 19948504

Targeted SERCA2a gene expression identifies molecular mechanism and therapeutic target for arrhythmogenic cardiac alternans.

Michael J Cutler1, Xiaoping Wan, Kenneth R Laurita, Roger J Hajjar, David S Rosenbaum.   

Abstract

BACKGROUND: Beat-to-beat alternans of cellular repolarization is closely linked to ventricular arrhythmias in humans. We hypothesized that sarcoplasmic reticulum calcium reuptake by SERCA2a plays a central role in the mechanism of cellular alternans and that increasing SERCA2a gene expression will retard the development of cellular alternans. METHODS AND
RESULTS: In vivo gene transfer of a recombinant adenoviral vector with the transgene for SERCA2a (Ad.SERCA2a) was performed in young guinea pigs. Isolated myocytes transduced with Ad.SERCA2a exhibited improved sarcoplasmic reticulum Ca(2+) reuptake (P<0.05) and were markedly resistant to cytosolic calcium alternans (P<0.05) under repetitive constant action potential clamp conditions (ie, when alternation of action potential duration was prevented), proving that sarcoplasmic reticulum Ca(2+) cycling is an important mechanism in the development of cellular alternans. Similarly, SERCA2a overexpression in the intact heart demonstrated significant resistance to alternation of action potential duration when compared with control hearts (heart rate threshold, 484+/-25 bpm versus 396+/-11 bpm, P<0.01), with no change in action potential duration restitution slope. Importantly, SERCA2a overexpression produced a 4-fold reduction in susceptibility to alternans-mediated ventricular arrhythmias (P<0.05).
CONCLUSIONS: These data provide new evidence that sarcoplasmic reticulum Ca(2+) reuptake directly modulates susceptibility to cellular alternans. Moreover, SERCA2a overexpression suppresses cellular alternans, interrupting an important pathway to cardiac fibrillation in the intact heart.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19948504      PMCID: PMC2795134          DOI: 10.1161/CIRCEP.109.863118

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  42 in total

1.  Mechanisms of discordant alternans and induction of reentry in simulated cardiac tissue.

Authors:  Z Qu; A Garfinkel; P S Chen; J N Weiss
Journal:  Circulation       Date:  2000-10-03       Impact factor: 29.690

Review 2.  Cardiac alternans: diverse mechanisms and clinical manifestations.

Authors:  B Surawicz; C Fisch
Journal:  J Am Coll Cardiol       Date:  1992-08       Impact factor: 24.094

Review 3.  Altered cardiac myocyte Ca regulation in heart failure.

Authors:  Donald M Bers
Journal:  Physiology (Bethesda)       Date:  2006-12

4.  Focal modification of electrical conduction in the heart by viral gene transfer.

Authors:  J K Donahue; A W Heldman; H Fraser; A D McDonald; J M Miller; J J Rade; T Eschenhagen; E Marbán
Journal:  Nat Med       Date:  2000-12       Impact factor: 53.440

5.  Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a.

Authors:  S E Harding; U Schmidt; T Matsui; Z B Kang; G W Dec; J K Gwathmey; A Rosenzweig; R J Hajjar
Journal:  Circulation       Date:  1999-12-07       Impact factor: 29.690

6.  Intracellular Ca(2+) dynamics and the stability of ventricular tachycardia.

Authors:  E Chudin; J Goldhaber; A Garfinkel; J Weiss; B Kogan
Journal:  Biophys J       Date:  1999-12       Impact factor: 4.033

7.  Sarcoplasmic reticulum Ca(2+) release causes myocyte depolarization. Underlying mechanism and threshold for triggered action potentials.

Authors:  K Schlotthauer; D M Bers
Journal:  Circ Res       Date:  2000-10-27       Impact factor: 17.367

8.  Functional coupling between glycolysis and excitation-contraction coupling underlies alternans in cat heart cells.

Authors:  J Hüser; Y G Wang; K A Sheehan; F Cifuentes; S L Lipsius; L A Blatter
Journal:  J Physiol       Date:  2000-05-01       Impact factor: 5.182

9.  Insulin resistance and abnormal electrocardiograms in patients with high blood pressure.

Authors:  W H Sheu; C Y Jeng; S M Shieh; M M Fuh; D D Shen; Y D Chen; G M Reaven
Journal:  Am J Hypertens       Date:  1992-07       Impact factor: 2.689

10.  Prevention of ventricular arrhythmias with sarcoplasmic reticulum Ca2+ ATPase pump overexpression in a porcine model of ischemia reperfusion.

Authors:  Fabrice Prunier; Yoshiaki Kawase; Davide Gianni; Cristina Scapin; Stephan B Danik; Patric T Ellinor; Roger J Hajjar; Federica Del Monte
Journal:  Circulation       Date:  2008-07-21       Impact factor: 29.690

View more
  62 in total

1.  Calcium alternans in a couplon network model of ventricular myocytes: role of sarcoplasmic reticulum load.

Authors:  Michael Nivala; Zhilin Qu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-06-01       Impact factor: 4.733

Review 2.  Role of substrate and triggers in the genesis of cardiac alternans, from the myocyte to the whole heart: implications for therapy.

Authors:  Faisal M Merchant; Antonis A Armoundas
Journal:  Circulation       Date:  2012-01-24       Impact factor: 29.690

Review 3.  Regenerative therapies in electrophysiology and pacing: introducing the next steps.

Authors:  Gerard J J Boink; Michael R Rosen
Journal:  J Interv Card Electrophysiol       Date:  2010-12-16       Impact factor: 1.900

Review 4.  Usefulness of T-wave alternans in sudden death risk stratification and guiding medical therapy.

Authors:  Tuomo Nieminen; Richard L Verrier
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-07       Impact factor: 1.468

5.  Upregulation of SERCA2a following short-term ACE inhibition (by enalaprilat) alters contractile performance and arrhythmogenicity of healthy myocardium in rat.

Authors:  Marek Matus; Dana Kucerova; Peter Kruzliak; Adriana Adameova; Gabriel Doka; Katarina Turcekova; Jana Kmecova; Jan Kyselovic; Peter Krenek; Uwe Kirchhefer; Frank U Mueller; Peter Boknik; Jan Klimas
Journal:  Mol Cell Biochem       Date:  2015-02-08       Impact factor: 3.396

Review 6.  Gene therapy for ventricular tachyarrhythmias.

Authors:  J K Donahue
Journal:  Gene Ther       Date:  2012-04-26       Impact factor: 5.250

Review 7.  Cardiac gene therapy with SERCA2a: from bench to bedside.

Authors:  Judith K Gwathmey; Alexan I Yerevanian; Roger J Hajjar
Journal:  J Mol Cell Cardiol       Date:  2010-11-18       Impact factor: 5.000

8.  Targeted antioxidant treatment decreases cardiac alternans associated with chronic myocardial infarction.

Authors:  Bradley N Plummer; Haiyan Liu; Xiaoping Wan; Isabelle Deschênes; Kenneth R Laurita
Journal:  Circ Arrhythm Electrophysiol       Date:  2014-12-09

Review 9.  Gene therapy to treat cardiac arrhythmias.

Authors:  Rossana Bongianino; Silvia G Priori
Journal:  Nat Rev Cardiol       Date:  2015-04-28       Impact factor: 32.419

10.  TFAM overexpression reduces pathological cardiac remodeling.

Authors:  George H Kunkel; Christopher J Kunkel; Hazel Ozuna; Irina Miralda; Suresh C Tyagi
Journal:  Mol Cell Biochem       Date:  2018-10-23       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.